References
- TNM classification of malignant tumours. UICC, Third edition. Geneva 1978
- Rose M A, Shipley W U. Radiation therapy in invasive bladder cancer: principles, results, patient selection and innovations. The management of bladder cancer, D Raghavan. Edward Arnold, London 1988; 154–73
- Hendry W F. Diagnosis and management of primary bladder cancer: a British perspective. The management of bladder cancer, D Raghavan. Edward Arnold, London 1988; 69–93
- Scher H I. Systemic chemotherapy in regionally advanced bladder cancer. Theoretical considerations and results. Urol Clin North Am 1992; 19: 747–59
- Ackland S P, Vogelzang N J. New drugs and old toxicities. The management of bladder cancer, D Raghavan. Edward Arnold, London 1988; 189–227
- Sternberg C N, Yagoda A, Scher H I, et al. Preliminary results of M-VAC for transitional cell carcinoma of the urothelium J. Urol 1987; 133: 403–7
- Harker W G, Meyers F J, Freiha F S. Cisplatin, methotrexate and vinblastine (CMV): an effective chemotherapy regimen for metastatic transitional cell carcinoma of the urinary tract. J Clin Oncol 1985; 3: 1463–70
- Raghavan D. The management of bladder cancer: current practice and future prospects. The management of bladder cancer, D Raghavan. Edward Arnold, London 1988; 317–32
- Asano K, Masuda F, Suzuki H, Takamizawa S, Kaneko R. Study of the combined M-VAC therapy in invasive bladder cancer. Hinyokika Kiyo 1991; 37: 1645–50
- Nussbaum B, Mukamel E, Figer A, Servadio C, Lurie M. Neoadjuvant M-VAC chemotherapy for invasive TCC of the bladder (Meeting abstract). Third International Congress on Neoadjuvant Chemotherapy, ParisFrance, 1991; 33
- Seidman A D, Scher H I. The evolving role of chemotherapy for muscle infiltrating bladder cancer. Semin Oncol 1991; 18: 585–95
- Charrot-Chinet P. Noeadjuvant or preliminary chemotherapy in cancer of the bladder. Evaluation Ann Urol (Paris) 1992; 26: 25–9
- Dirix L Y, van Oosterom A T. Neoadjuvant and adjuvant therapy for invasive bladder tumours. Eur J Cancer 1991; 27: 326–30
- Kamoto T, Kawakita M, Okabe T, et al. Neoadjuvant chemotherapy (M-VAC) for locally invasive bladder cancer. Hinyokika Kiyo 1992; 38: 405–11
- Splinter T A, Scher H I, Dennis L, et al. The prognostic value of the pathological response to combination chrmotherapy before cystectomy in patients with invasive bladder cancer. EORTC-genitourinary group. J Urol 1992; 147: 606–8
- Theodore C, Azab M, Perrin J L, Court B, Droz J P. Neoadjuvant chemotherapy with CMV for invasive bladder cancer. (Meeting abstract.) Proc Annu Meet Am Soc Clin Oncol 1992; 11: A668
- Rintala E, Hannisdahl E, Fosså S D, Hellsten S, Sander S. Neoadjuvant chemotherapy in bladder cancer: a randomized study. Scand J Urol Nephrol 1993; 27: 355–62
- Bergkvist A, Ljungqvist A, Moberger G. Classification of bladder tumours based on the cellular pattern: preliminary report of a clinical-pathological study of 300 cases with a minimum follow-up of eight years. Acta Chir Scand 1965; 130: 371–8
- Malmström P-U, Lönnemark M, Busch C, Magnusson A. Staging of bladder carcinoma by computer tomography guided transmural core biopsy. Scan J Urol Nephrol 1993; 27: 193–8